About Javara Research
Javara Research is a company based in Winston-salem (United States) founded in 2018. Javara Research has raised $44.98 million across 5 funding rounds from investors including General Atlantic. Javara Research offers products and services including CRAACO Service and Infrastructure Provision. Javara Research operates in a competitive market with competitors including Vial, Alcanza Clinical Research, Global Coalition for Adaptive Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.
- Headquarter Winston-salem, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$44.98 M (USD)
in 5 rounds
-
Latest Funding Round
$6.6 M (USD), Series B
May 13, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Javara Research
Javara Research offers a comprehensive portfolio of products and services, including CRAACO Service and Infrastructure Provision.
Connects patients to trials at point of care for better access.
Offers training and infrastructure for conducting clinical trials efficiently.
People of Javara Research
Unlock access to complete
Unlock access to complete
Funding Insights of Javara Research
Javara Research has successfully raised a total of $44.98M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6.6 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $6.6M
-
First Round
First Round
(13 Aug 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series B - Javara Research | Valuation |
investors |
|
| Nov, 2023 | Amount | Debt – Conventional - Javara Research | Valuation |
investors |
|
| Apr, 2022 | Amount | Series B - Javara Research | Valuation | General Atlantic |
|
Investors in Javara Research
Javara Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include General Atlantic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location |
Investments & Acquisitions by Javara Research
Financial Statements - Javara Research
Javara Research Comparisons
Competitors of Javara Research
Javara Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vial, Alcanza Clinical Research, Global Coalition for Adaptive Research, Clinical Pharmacology of Miami and The START Center for Cancer Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Healthcare data capture, clinical trials, and CRO services are provided.
|
|
| domain | founded_year | HQ Location |
Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation
|
|
| domain | founded_year | HQ Location |
Nonprofit organization sponsors clinical trials for rare diseases worldwide.
|
|
| domain | founded_year | HQ Location |
Clinical research unit for phase I, II and III trials
|
|
| domain | founded_year | HQ Location |
Early-phase oncology clinical trials and research services are provided.
|
Frequently Asked Questions about Javara Research
Javara Research was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Javara Research is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Jennifer Byrne is the current CEO of Javara Research.
Javara Research is a funded company, having raised a total of $44.98M across 5 funding rounds to date. The company's 1st funding round was a Series B of $30M, raised on Aug 13, 2019.
Javara Research was founded in 2018 in Winston-Salem, United States, as a clinical research entity focused on the pharmaceutical sector. Trials are carried out in a broad spectrum of therapeutic areas, supported by an integrated platform designed for streamlined operations. Services encompass trial management and execution, with activities centered in the U.S. to facilitate industry partnerships and research advancements.
Javara Research's top competitors include Vial, The START Center for Cancer Research and Summit Clinical Research.
Javara Research offers CRAACO Service and Infrastructure Provision.
Javara Research has 1 investor. Key investors include General Atlantic.